Oral Bifidobacterium can increase tumor cell control and contributes to interferon (IFN)-γ production by CD8+ tumor-specific T cells, and further increases the activation of intratumoral dendritic cells to improve anti-PD-L1 efficacy. The gene discussed is CD8A; the disease is neoplasm.